pAP1-3 Citations (1)
Originally described in: Development of receptor and oncogene-responsive luciferase reporter vectors that are activated via kinase signalling to AP-1.Danial J L Coleman, Luke Ames, Hurooul Aain, Joanna Gamble, Kinga Koscielniak, Zijin Zhang, Cherisse Lau, Abigail Joyce, and Peter N Cockerill. Experimental Hematology, 2026 Journal
Articles Citing pAP1-3
| Articles |
|---|
| Disease-associated polymorphisms within the conserved ECR1 enhancer differentially regulate the tissue-specific activity of the cannabinoid-1 receptor gene promoter; implications for cannabinoid pharmacogenetics. Hay EA, Cowie P, McEwan AR, Ross R, Pertwee RG, MacKenzie A. Hum Mutat. 2020 Jan;41(1):291-298. doi: 10.1002/humu.23931. Epub 2019 Nov 4. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.